Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Cited In for PubMed (Select 16199061)

1.

Impact of Cannabis Use on the Development of Psychotic Disorders.

Wilkinson ST, Radhakrishnan R, D'Souza DC.

Curr Addict Rep. 2014 Jun 1;1(2):115-128.

2.

Ethnomedicinal and phytochemical review of Pakistani medicinal plants used as antibacterial agents against Escherichia coli.

Adnan M, Bibi R, Mussarat S, Tariq A, Shinwari ZK.

Ann Clin Microbiol Antimicrob. 2014 Aug 19;13:40. doi: 10.1186/s12941-014-0040-6. Review.

3.

Open-label pilot study of quetiapine treatment for cannabis dependence.

Mariani JJ, Pavlicova M, Mamczur AK, Bisaga A, Nunes EV, Levin FR.

Am J Drug Alcohol Abuse. 2014 Jul;40(4):280-4. doi: 10.3109/00952990.2014.884102.

4.

The cannabinoid acids, analogs and endogenous counterparts.

Burstein SH.

Bioorg Med Chem. 2014 May 15;22(10):2830-43. doi: 10.1016/j.bmc.2014.03.038. Epub 2014 Apr 1. Review.

5.

CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex.

Cass DK, Flores-Barrera E, Thomases DR, Vital WF, Caballero A, Tseng KY.

Mol Psychiatry. 2014 May;19(5):536-43. doi: 10.1038/mp.2014.14. Epub 2014 Mar 4.

6.

Cannabidiol in humans-the quest for therapeutic targets.

Zhornitsky S, Potvin S.

Pharmaceuticals (Basel). 2012 May 21;5(5):529-52. doi: 10.3390/ph5050529.

7.

Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.

Chadwick B, Miller ML, Hurd YL.

Front Psychiatry. 2013 Oct 14;4:129. doi: 10.3389/fpsyt.2013.00129. Review.

8.

Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.

Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, Whalley BJ, Hill AJ.

Br J Pharmacol. 2013 Oct;170(3):679-92. doi: 10.1111/bph.12321.

9.

Spicing things up: synthetic cannabinoids.

Spaderna M, Addy PH, D'Souza DC.

Psychopharmacology (Berl). 2013 Aug;228(4):525-40. doi: 10.1007/s00213-013-3188-4. Epub 2013 Jul 9. Review.

10.

Marijuana dependence: not just smoke and mirrors.

Ramesh D, Schlosburg JE, Wiebelhaus JM, Lichtman AH.

ILAR J. 2011;52(3):295-308. doi: 10.1093/ilar.52.3.295.

11.

Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences.

Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R.

Neuropsychol Rev. 2013 Jun;23(2):117-37. doi: 10.1007/s11065-012-9222-1. Epub 2012 Nov 6. Review.

12.

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.

Puighermanal E, Busquets-Garcia A, Maldonado R, Ozaita A.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3254-63. doi: 10.1098/rstb.2011.0384. Review.

13.

Cannabidivarin is anticonvulsant in mouse and rat.

Hill AJ, Mercier MS, Hill TD, Glyn SE, Jones NA, Yamasaki Y, Futamura T, Duncan M, Stott CG, Stephens GJ, Williams CM, Whalley BJ.

Br J Pharmacol. 2012 Dec;167(8):1629-42. doi: 10.1111/j.1476-5381.2012.02207.x.

14.

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.

Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D.

Drug Alcohol Depend. 2013 Feb 1;128(1-2):64-70. doi: 10.1016/j.drugalcdep.2012.08.001. Epub 2012 Aug 22.

15.

Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides.

Gagne SJ, Stout JM, Liu E, Boubakir Z, Clark SM, Page JE.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12811-6. doi: 10.1073/pnas.1200330109. Epub 2012 Jul 16.

16.

Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice.

Wiebelhaus JM, Poklis JL, Poklis A, Vann RE, Lichtman AH, Wise LE.

Drug Alcohol Depend. 2012 Dec 1;126(3):316-23. doi: 10.1016/j.drugalcdep.2012.05.034. Epub 2012 Jul 7.

17.

Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia.

Caballero A, Tseng KY.

Front Pharmacol. 2012 May 28;3:101. doi: 10.3389/fphar.2012.00101. eCollection 2012.

18.

Multiple functions of endocannabinoid signaling in the brain.

Katona I, Freund TF.

Annu Rev Neurosci. 2012;35:529-58. doi: 10.1146/annurev-neuro-062111-150420. Epub 2012 Apr 17. Review.

19.

Cannabinoid receptors: nomenclature and pharmacological principles.

Console-Bram L, Marcu J, Abood ME.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):4-15. doi: 10.1016/j.pnpbp.2012.02.009. Epub 2012 Feb 28. Review.

20.

Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Tambaro S, Bortolato M.

Recent Pat CNS Drug Discov. 2012 Apr 1;7(1):25-40. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk